Global & Egypt Pressure Monitoring Devices Market to 2033

The market for pressure monitoring devices in Egypt is experiencing significant growth, primarily driven by the increasing prevalence of noncommunicable diseases (NCDs), a gradually aging population, and a strong governmental initiative aimed at achieving comprehensive digital transformation in the healthcare sector. Hypertension, in particular, is a major health concern in Egypt, with national surveys indicating that approximately 26.3% of adults aged 25 and older are affected. This figure rises dramatically to 56.6% among individuals aged 75 and above, highlighting the urgent need for effective monitoring and management of blood pressure.

Data from the World Health Organization (WHO) reveals a concerning trend in Egypt's health landscape, as the healthier life expectancy has declined from 2000 to 2021. This decline points to an increasing burden of chronic health conditions, which necessitates the implementation of effective monitoring solutions. Although specific statistics regarding the NCD burden for the years 2024 to 2025 are still being compiled, the Egypt National Health Strategy for 2024 to 2030 acknowledges the significant health challenges faced by the population. The high prevalence of NCDs underscores the importance of widespread adoption of reliable and accessible pressure monitoring devices, which are essential for early detection, accurate diagnosis, and ongoing management of these conditions.

Despite the challenges posed by NCDs, Egypt's population remains relatively young, with only about 6.2% of individuals aged 65 and older as of 2023. However, the overall population is on the rise, and this demographic shift will inevitably lead to an increase in the number of people susceptible to age-related health issues that require continuous monitoring. As the population ages, the demand for effective pressure monitoring solutions will likely grow, making it imperative for healthcare providers to adapt to these changing needs.

Technological advancements are playing a crucial role in shaping the pressure monitoring devices market in Egypt. The country is making significant progress in the realm of digital health, with the Ministry of Health and Population (MoHAP) leading a comprehensive digital transformation initiative. By June 2025, nearly 20 million electronic treatment approvals were issued during the 2024/2025 fiscal year through the General Authority for Health Insurance, marking a notable achievement in the digitization of healthcare services. Furthermore, over 13 million online appointments have been scheduled across 250 clinics, with an additional 120 clinics undergoing digital transformation.

In addition to these advancements, 160 clinic archives and 239 medical warehouses have been fully digitized, and there are plans to automate specialized medical committees, including those focused on cardiology. This extensive digitalization creates a favorable environment for the adoption of smart, connected pressure monitoring devices, which facilitate remote patient monitoring and enhance overall healthcare efficiency.

The telemedicine market in the Middle East and North Africa (MENA) region, which encompasses Egypt, is poised for substantial growth, particularly in the areas of real-time consultations and remote monitoring. This transformation is being strongly supported by government initiatives aimed at improving healthcare delivery. The Egypt National Health Strategy for 2024 to 2030 serves as a strategic framework for the healthcare sector, aligning with the broader Vision 2030 and the United Nations Sustainable Development Goals.

In a bid to bolster the healthcare sector, the government has increased the budget for healthcare by 24.9% for the new fiscal year 2024/2025, bringing the total to approximately EGP 496 billion. This financial commitment reflects the government's dedication to enhancing healthcare services and infrastructure. Additionally, MoHAP has partnered with eHealth to manage and operate Egypt's national digital health system, with the goal of developing a comprehensive roadmap for digital transformation, establishing the necessary technological infrastructure, and attracting private sector investment.

Regulatory developments are also playing a vital role in ensuring the quality and safety of medical products in the market. The Egyptian Drug Authority (EDA) has introduced Decree 39 of 2025, which will take effect on July 1, 2025. This decree sets forth guidelines for the importation and handling of medical products, thereby enhancing the regulatory framework governing the healthcare sector.

These collective efforts underscore Egypt's commitment to modernizing its healthcare system, making advanced pressure monitoring devices more accessible and seamlessly integrated into the broader digital health ecosystem. As the country continues to navigate the challenges posed by NCDs and an evolving demographic landscape, the emphasis on digital health and innovative monitoring solutions will be crucial in improving health outcomes for the Egyptian population. Show more